Stock Information
Agios Pharmaceuticals Inc (AGIO)
Ticker Symbol: AGIO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,639.99 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -7.2504
Revenue (TTM): $1.12 M
Dividend Yield: N/A%
ROE: -34.11%
Latest News
-
Agios: 'Sell' On Tebapivat Setback LR-MDS And Competitive PK Activator Drug Class
Fri, May 29, 2026 4:11 PM
-
B of A Securities Maintains Buy on Agios Pharmaceuticals, Lowers Price Target to $40
Fri, May 29, 2026 2:19 PM
-
Agios Pharma Says It Will Not Advance Tebapivat, Next-Gen Oral Pyruvate Kinase Activator, In Lower-Risk Myelodysplastic Syndromes As Phase 2b Trial Results Did Not Meet Predefined Threshold To Support Further Development In LR-MDS
Fri, May 29, 2026 7:02 AM
-
Agios Pharmaceuticals Announces EU Marketing Authorization For PYRUKYND In Adults For Treatment Of Anemia
Fri, May 22, 2026 9:18 AM
Key Financials
Financial data not available
